SAPIENS ANNOUNCES Q1 2008 RESULTS (Emblaze)

Date : 05/21/2008 @ 7:49AM
Source : UK Regulatory (RNS and others)
Stock : Emblaze Ltd (BLZ)
Quote : 31.0  1.5 (5.08%) @ 11:35AM
<< BackQuote Chart

 



SAPIENS ANNOUNCES Q1 2008 RESULTS (Emblaze)

    SAPIENS ANNOUNCES Q1 2008 RESULTS                       

  Company Continues to Improve Performance for the Sixth Consecutive Quarter   

Ra'anana, Israel, 21 May 2008 - Emblaze Ltd (LSE:BLZ) ("Emblaze" or "the
Group") announces that Sapiens International Corporation N.V. (NASDAQ and TASE:
SPNS), a member of the Emblaze/ Formula Group (NASDAQ: FORTY and TASE: FORT),
announced yesterday its results of operations for the first quarter of 2008.

Highlights for Q1 2008

  * Sixth consecutive quarter of Operating Profit of $US423,000, a significant
    increase of 41%
   
from the fourth quarter of 2007

  * Approximately $US400,000 Cash Flow from Operations, following upon the
    positive Cash Flow from Operations in 2007
   
  * Revenue of $US10.5 million, a 3.1% increase from the fourth quarter of 2007
   
  * Signed a major agreement, for $US1 million, in Japan
   
  * Increased pipeline of potential deals with major customers
   
  * Repurchase of Debentures in Q1 2008 of $US2.1 million
   
  * The increase in Financial Expenses is due to the devaluation of the US
    Dollar vs. the New Israeli Shekel
   
U.S. GAAP

  * Operating Profit of $US423,000, a 184% increase from the first quarter of
    2007 and a significant increase of 41% from the fourth quarter of 2007
   
Non-GAAP

  * Operating Profit of $US522,000, a turn around from the Operating Loss of
    $US2,000 in the First Quarter of 2007, and a significant increase of 35%
    from $386,000 in the Fourth Quarter of 2007
   
U.S. GAAP results include amortization of capitalized software developments,
capitalization of software development costs, and stock-based compensation
expenses.

Reconciliation between U.S. GAAP and Non-GAAP results is summarized in the
following table. For a complete reconciliation, please refer to the tables at
the end of this release.

U.S. Dollars in thousands, except per 
            share amounts             

                             For the three months   
                                     ended          
                                                    
                           03/31/2008   03/31/2007  
                                                    
                           (Unaudited)  (Unaudited) 
                                                    
U.S. GAAP                                           
                                                    
Revenues                      10,491      11,007       
                                                    
Operating profit               423         149          
                                                    
Net loss                      (1,200)     (405)        
                                                    
Basic and diluted loss per     (0.06)     (0.03)       
share                                               
                                                    
                                                    
                                                    
Non-GAAP                                            
                                                    
Revenues                      10,491      11,007       
                                                    
Operating profit (loss)        522         (2)          
                                                    
Net loss                      (1,101)     (556)        
                                                    
Basic and diluted loss per    (0.05)      (0.04)       
share                                               

Roni Al-Dor, President and CEO, commented "We report our sixth consecutive
quarter of operating profit. We also report approximately $US400,000 positive
cash flow from operations for the first quarter of 2008. We are now benefitting
from our past activities to increase efficiencies at each of our subsidiaries.
We have stabilized our ship and are sailing forward. We have increased our lead
generation and face several promising opportunities that we expect will become
signed agreement in 2008. Due to the devaluation of the US Dollar against the
New Israeli Shekel, we had an increase in finance expenses which created an
increase in our Net Loss."

Mr. Al-Dor added, "We thank our customers, our investors and our employees for
the good news we report today. We believe that our positive trend will continue
and that we will have more good news to report to you in the future."

Comment Regarding Non-GAAP

Sapiens' management believes that the presentation of non-GAAP measures can
enhance the understanding of the company's ongoing economic performance, and
provides useful information to investors regarding financial and business
trends relating to the company's financial condition and results of operations.
Sapiens therefore uses internally the non-GAAP information to evaluate and
manage the Company's operations.

This non-GAAP financial measures are not in accordance with, or an alternative
for, generally accepted accounting principles and may be different from
non-GAAP financial measures used by other companies. In addition, these
non-GAAP financial measures are not based on any comprehensive set of
accounting rules or principles. Sapiens believes that non-GAAP financial
measures have limitations in that they do not reflect all of the amounts
associated with Sapiens' results of operations as determined in accordance with
GAAP and that these measures should only be used to evaluate Sapiens' results
of operations in conjunction with the corresponding GAAP measures.

Please refer to the Reconciliation of GAAP to Non-GAAP Results at the end of
this release.

Enquiries:

Emblaze                                                            
                                                                   
Hadas Gazit, Hagit Gal               + 972 9 7699302/ 339          

About Sapiens International

Sapiens International Corporation N.V. (Nasdaq and TASE: SPNS), a member of
Formula Group (Nasdaq: FORTY and TASE: FORT), which is a member of the Emblaze
Group (LSE: BLZ.L) is a leading global provider of proven IT solutions that
modernize business processes and enable insurance organizations to adapt
quickly to change. Sapiens' innovative solutions are widely recognized for
their ability to cost-effectively align IT with the business demands for speed,
flexibility and efficiency. Sapiens operates through its subsidiaries in North
America, the United Kingdom, EMEA and Asia Pacific, and has partnerships with
market leaders such as IBM and EDS. Sapiens' clients include AXA, ING,
Liverpool Victoria, Menora Mivtachim, Norwich Union, Occidental Fire &
Casualty, OneBeacon, Principal Financial Group, Santam and Texas Farm Bureau
among others. For more information, please visit http://www.sapiens.com.

Except for historical information contained herein, the matters set forth in
this release are forward-looking statements that are dependent on certain risks
and uncertainties, including such factors, among others, as market acceptance,
market demand, pricing, changing regulatory environment, changing economic
conditions, risks in new product and service development, the effect of the
Company's accounting policies, specific system configurations and software
needs of individual customers and other risk factors detailed in the Company's
SEC filings.

About Emblaze

Emblaze Ltd is a group of technology companies addressing both growth and
innovation activities thus combining the stability of "bread and butter" mature
technology enterprises with "high-risk / high-reward" investments in
innovation.

Our Growth arm includes Formula Systems (NASDAQ: FORTY and TASE: FORT), which
harbors the following subsidiaries: Magic Software Enterprises Ltd. (NASDAQ &
TASE: MGIC) develops, markets and supports composite application development
and deployment platforms with a service-oriented architecture (SOA), including
application integration and business process management (BPM), with existing
and legacy systems; Matrix IT Ltd. (TASE: MTRX) is one of Israel's leading
integration and information technology services companies, active in four
principal areas: software solutions and services, software products,
infrastructure solutions and hardware products, and training and assimilation.;
Sapiens International Corporation N.V. (NASDAQ & TASE: SPNS) is a provider of
IT solutions that modernize business processes to enable insurance and other
companies to quickly adapt to changes; and nextSource Inc., designs, develops
and implements web-based, high quality, innovative human capital management
solutions.

Our Innovation arm includes Emblaze Mobile, a designer of advanced mobile
devices; EMOZE, a provider of Push Email and synchronisation technology for
mobile devices; and ZONE-IP (LSE: ZIP) (Emblaze V CON), a provider of wireless
video communications technologies and conferencing solutions for operators and
enterprise markets over IP networks.

The Emblaze Group is traded on the London Stock Exchange (LSE: BLZ) since 1996.
www.Emblaze.com

                SAPIENS INTERNATIONAL CORPORATION N.V.                 
                                                                       
                 Condensed Consolidated Balance Sheets                 
                                                                       
                      (U.S. Dollars in thousands)                      
                                                                       
                                              03/31/2008     12/31/2007 
                                                                       
                                              (Unaudited)    (Unaudited)
                                                                       
Assets                                                                 
                                                                       
    Cash and cash equivalents                    $10,523        $13,125
                                                                       
    Trade receivables, net                         8,722          7,549
                                                                       
    Other current assets                           1,810          1,835
                                                                       
    Total current assets                          21,055         22,509
                                                                       
    Property and equipment, net                    1,158          1,219
                                                                       
    Other assets,                                 29,731         28,804
    net                                                                
                                                                       
Total assets                                    $ 51,944       $ 52,532
                                                                       
Liabilities and shareholders' equity                                   
                                                                       
    Short-term bank credit and current                                 
    maturities                                                         
                                                                       
    of long-term debt and convertible             $8,184         $9,456
    debentures                                                         
                                                                       
    Trade payables                                 1,481          1,088
                                                                       
    Other liabilities and accrued                  9,292          8,375
    expenses                                                           
                                                                       
    Deferred                                       4,322          4,203
    revenue                                                            
                                                                       
    Total current liabilities                     23,279         23,122
                                                                       
    Long-term debt and other long-term             1,450          1,132
    liabilities                                                        
                                                                       
    Convertible debentures                         5,440          6,428
                                                                       
    Shareholders' equity                          21,775         21,850
                                                                       
Total liabilities and shareholders'             $ 51,944       $ 52,532  
equity                                                                 

                 SAPIENS INTERNATIONAL CORPORATION N.V.                  
                                                                         
             Condensed Consolidated Statements of Operations             
                                                                         
          (U.S. Dollars in thousands, except per share amounts)          

                                              For the three months ended 
                                                                         
                                             03/31/2008     03/31/2007  
                                                                         
                                                                         
                                                                         
                                             (Unaudited)   (Unaudited)  
                                                                         
Revenues                                        $ 10,491      $ 11,007      
                                                                         
Cost of revenues                                 $ 6,256       $ 7,076       
                                                                         
Gross Profit                                       4,235         3,931         
                                                                         
Operating expenses                                                       
                                                                         
Research and development, net                      $ 790         $ 490         
                                                                         
Selling, marketing, general and                  $ 3,022       $ 3,292       
administrative (a)                                                       
                                                                         
Operating Profit                                     423           149           
                                                                         
Financial expenses, net                          $ 1,183         $ 424         
                                                                         
Other expenses, net (b)                            $ 440         $ 130         
                                                                         
Net Loss                                         $ 1,200         $ 405         
                                                                         
Basic and diluted loss per share (c)              $ 0.06        $ 0.03        
                                                                         
Weighted average shares used to compute -                                
                                                                         
basic and diluted loss per share (c)              21,550        14,854        
                                                                         

Note

a: Certain prior year's amounts have been reclassified and corrected to conform
with current year presentation

b: Includes taxes, equity losses, minority interest and capital losses due to
repurchase of debentures.

c: Due to the net loss in the three month period ended March 31, 2007 and 2008
the inclusion of dilutive securities would be antidilutive.

                   SAPIENS INTERNATIONAL CORPORATION N.V.                    
                                                                             
                 Reconciliation of GAAP to Non-GAAP results                  
                                                                             
            (U.S. Dollars in thousands, except per share amounts)            
                                                                             
                                            For the three months ended       
                                                                             
                                           03/31/2008       03/31/2007       
                                                                             
                                          (Unaudited)      (Unaudited)       
                                                                             
GAAP operating profit                        423             149                
                                                                             
Amortization of intangibles                  960             1,183              
                                                                             
Capitalization of software                  (876)           (1,341)            
development                                                                  
                                                                             
Stock-based compensation                     15              7                  
                                                                             
Total adjustments to GAAP                    99              (151)              
                                                                             
Non-GAAP operating profit (loss)             522             (2)                
                                                                             
GAAP net loss                               (1,200)          (405)              
                                                                             
Total adjustments to GAAP as above           99              (151)              
                                                                             
Non-GAAP net loss                           (1,101)          (556)              
                                                                             
Non-GAAP basic loss per share               (0.05)          (0.04)             
                                                                             
Weighted average number of ordinary         21,550          14,854             
shares used in computing basic net                                           
loss per ordinary share                                                      



END

<< Back


Emblaze Ltd Historical Chart Emblaze Ltd Intraday Chart  
Period


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
30 site:2us 080821 19:20 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )